Browsing by Author Subramanian, GM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 4 of 4
TitleAuthor(s)Issue Date
 
Characterization of HBsAg decline in the Tenofovir disoproxil fumarate (TDF) and peginterferon alfa 2A (PEG) combination study for chronic hepatitis B (CHB)
Proceeding/Conference:Hepatology International
Chan, HLYKadayifci, APapatheodoridis, GYuen, MFChien, RNKwan, WCPLin, LDinh, PMartins, EBCharuworn, PSubramanian, GMMchutchison, JGPetersen, JShiffman, MReesink, HWLim, SGLim, YSMarcellin, P
2015
 
RETRACTION: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection
Journal:Clinical Gastroenterology and Hepatology
Seto, WKWAsahina, YBrown, TTPeng, CYStanciu, CAbdurakhmanov, DTabak, FNguyen, TTChuang, WLInokuma, TIkeda, FSantantonio, TAHabersetzer, FRamji, ALau, AHSuri, VFlaherty, JFWang, HGaggar, ASubramanian, GMMukewar, SBrunetto, MRFung, SChan, HL
2018
 
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Journal:The Lancet Gastroenterology & Hepatology
Chan, HLFung, SSeto, WKWChuang, WLChen, CYKim, HJHui, AJJanssen, HChowdhury, ATsang, TYRajiv, MGane, EFlaherty, JMassetto, BGaggar, AKitrinos, KMLin, LSubramanian, GMMcHutchison, JLim, YSAcharya, SKAgarwal, K
2016
 
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Journal:The Lancet Gastroenterology & Hepatology
Buti, MGane, ESeto, WKWChan, HLChuang, WLStepanova, THui, AJLim, YSMehta, RJanssen, HAcharya, SKFlaherty, JMassetto, BCathcart, ALKim, KGaggar, ASubramanian, GMMcHutchison, JPan, CBrunetto, MIzumi, NMarcellin, P
2016
Showing results 1 to 4 of 4